NCT02597725

Brief Summary

The purpose of this study is to describe the urinary morbidity as a result surgery and radiation therapy, in patients treated for prostate cancer. All the patients will undergo a Urodynamic examination to verify the grade of Urinary morbidity.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2015

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2015

Completed
25 days until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 5, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

November 5, 2015

Status Verified

October 1, 2015

Enrollment Period

8 months

First QC Date

October 7, 2015

Last Update Submit

November 4, 2015

Conditions

Keywords

UrodynamicsLate effectsUrinary Incontinence

Outcome Measures

Primary Outcomes (4)

  • Spontaneous urinary flow

    The patients load the water at a special flow toilet

    2 minutes

  • Biomechanical properties of urethra

    Evaluation of biomechanical wall properties by measuring luminal cross-sectional area and pressure.

    10 minutes

  • Cystometri

    The bladder is filled with saline with a flow rate of 60 mL/minute.

    20 minutes

  • Uretal pressure profile

    To evaluate the uretal pressure profile. The water pump perfused saline at a flow rate of 1 mL, while the catheter. attached to an automatic pulling device, was pulled out of the urethra at 2 mm/s.

    10 minutes

Study Arms (1)

Urodynamics

There is no intervention in this study.

Eligibility Criteria

Age50 Years - 90 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The patients in this cohort had surgery for prostate cancer in the period from 1999-2009. Because of a locale disease relapse the patients were treated with Salvage radiation therapy in the period from 2006-2010.

You may qualify if:

  • Patients treated with salvage radiotherapy at Aarhus University hospital in the period from 2006-2010.

You may not qualify if:

  • Other cancer types
  • Severe comorbidity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Prostatic NeoplasmsUrinary Incontinence

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Borre, Professor

    University of Aarhus

    STUDY CHAIR
  • Morten Høyer, Professor

    University of Aarhus

    STUDY CHAIR

Central Study Contacts

Maria Ervandian, MD

CONTACT

Helene Nørrelund

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2015

First Posted

November 5, 2015

Study Start

November 1, 2015

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

November 5, 2015

Record last verified: 2015-10